FDA Nod Lifts BioDelivery Sciences International, Inc. (BDSI), Puts Bears on Notice

A rare rally for BioDelivery Sciences International, Inc. (BDSI) may have option bears and short sellers on edge

Oct 26, 2015 at 12:01 PM
facebook X logo linkedin


BioDelivery Sciences International, Inc. (NASDAQ:BDSI) gapped up at the open, and at least check, was 13.5% higher at $5.99. The shares are being propelled by the Food and Drug Administration's (FDA) approval of the company's opioid-based pain treatment, Belbuca -- to which Endo International plc (NASDAQ:ENDP) has licensed global manufacturing and marketing rights. Amid these developments, BDSI options are flying off the shelves -- especially on the put side of the aisle, where the contracts are trading at 12 times the intraday norm.

Taking a step back, today's put-bias is business as usual. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), BDSI has racked up a 50-day put/call volume ratio of 0.59 -- which rests just 16 percentage points from a 52-week peak. In other words, traders have been buying to open puts over calls at a faster-than-usual clip in recent months.

Short sellers are similarly bearish. During the last two reporting periods, short interest on BDSI jumped 13%, and now makes up 29% of its total float -- the highest level in over a decade. At typical daily trading levels, it would take nearly seven sessions to repurchase these positions.

While these skeptics may be feeling the pain today, the fact is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has earned the negative attention. Year-to-date, the pharmaceutical stock has surrendered roughly half of its value, and hit a nearly two-year low of $4.66 late last month.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI